Supplemental material
Future Oncology
Volume 19, 2023 - Issue 18
Open access
1,087
Views
0
CrossRef citations to date
0
Altmetric
Research Article
Real-World Ramucirumab and Immune Checkpoint Inhibitor Sequences in US Patients with Advanced Gastroesophageal Cancer
Astra M Liepa1 Eli Lilly & Company,
Lilly Corporate Center,
Indianapolis,IN 46285,USACorrespondence[email protected]
https://orcid.org/0000-0002-1395-2831
Zhanglin Lin Cui1 Eli Lilly & Company,
Lilly Corporate Center,
Indianapolis,IN 46285,USA
, Julie K Beyrer1 Eli Lilly & Company,
Lilly Corporate Center,
Indianapolis,IN 46285,USA
, Elizabeth L Hadden1 Eli Lilly & Company,
Lilly Corporate Center,
Indianapolis,IN 46285,USA;2 DeLisle Associates LTD,
Cranbrook DR,
Indianapolis,IN46250,USA
& Anindya Chatterjee1 Eli Lilly & Company,
Lilly Corporate Center,
Indianapolis,IN 46285,USA
Pages 1277-1291
|
Received 15 Jun 2022, Accepted 26 Apr 2023, Published online: 17 May 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.